306 related articles for article (PubMed ID: 27866810)
1. Histological characterisation of visceral changes in a patient with type 2 Gaucher disease treated with enzyme replacement therapy.
Tezuka Y; Fukuda M; Watanabe S; Nakano T; Okamoto K; Kuzume K; Yano Y; Eguchi M; Ishimae M; Ishii E; Miyazaki T
Blood Cells Mol Dis; 2018 Feb; 68():194-199. PubMed ID: 27866810
[TBL] [Abstract][Full Text] [Related]
2. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].
Tóth J; Szücs FZ; Benkö K; Maródi L
Orv Hetil; 2003 Apr; 144(16):749-55. PubMed ID: 12778625
[TBL] [Abstract][Full Text] [Related]
3. Small Bowel Mucosal Involvement and Mesenteric Mass Formation in a Young Female with Type 3 Gaucher Disease. A Case Report.
Emanuel AJ; Holman N; Presnell SE; Welsh CT; Pai S; Sun S
J Gastrointestin Liver Dis; 2018 Dec; 27(4):459-463. PubMed ID: 30574629
[TBL] [Abstract][Full Text] [Related]
4. [French results of enzyme replacement therapy in Gaucher's disease].
Schaison G; Caubel I; Belmatoug N; Billette de Villemeur T; Saudubray JM
Bull Acad Natl Med; 2002; 186(5):851-61; discussion 861-3. PubMed ID: 12412377
[TBL] [Abstract][Full Text] [Related]
5. [A retrospective study on enzyme replacement therapy in patients with Gaucher disease].
Duan YL; Zhang YH; Zang Y; Shi HP; Zhang WM; Hu YM
Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):653-6. PubMed ID: 17217655
[TBL] [Abstract][Full Text] [Related]
6. Enzyme therapy in Gaucher disease type 2: an autopsy case.
Takahashi T; Yoshida Y; Sato W; Yano T; Shoji Y; Sawaishi Y; Sakuma I; Sashi T; Enomoto K; Ida H; Takada G
Tohoku J Exp Med; 1998 Oct; 186(2):143-9. PubMed ID: 10223617
[TBL] [Abstract][Full Text] [Related]
7. Marked clinical and histologic improvement in a patient with type-1 Gaucher's disease following long-term glucocerebroside substitution. A case report and review of current diagnosis and management.
Heukamp LC; Schröder DW; Plassmann D; Homann J; Büttner R
Pathol Res Pract; 2003; 199(3):159-63. PubMed ID: 12812317
[TBL] [Abstract][Full Text] [Related]
8. Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher Registry.
El-Beshlawy A; Tylki-Szymanska A; Vellodi A; Belmatoug N; Grabowski GA; Kolodny EH; Batista JL; Cox GF; Mistry PK
Mol Genet Metab; 2017; 120(1-2):47-56. PubMed ID: 28040394
[TBL] [Abstract][Full Text] [Related]
9. Enzyme Replacement Therapy in a Gaucher Family.
Erdem N; Buran T; Berber I; Aydogdu I
J Natl Med Assoc; 2018 Aug; 110(4):330-333. PubMed ID: 30126557
[TBL] [Abstract][Full Text] [Related]
10. [Gaucher disease: MR evaluation of bone marrow features during treatment with enzyme replacement].
Poll LW; vom Dahl S; Koch JA; Börner D; Willers R; Cohnen M; Jung G; Scherer A; Niederau C; Häussinger D; Mödder U
Rofo; 2001 Oct; 173(10):931-7. PubMed ID: 11588682
[TBL] [Abstract][Full Text] [Related]
11. Enzyme replacement therapy and bony changes in Egyptian paediatric Gaucher disease patients.
El-Beshlawy A; Ragab L; Youssry I; Yakout K; El-Kiki H; Eid K; Mansour IM; Abd El-Hamid S; Yang M; Mistry PK
J Inherit Metab Dis; 2006 Feb; 29(1):92-8. PubMed ID: 16601874
[TBL] [Abstract][Full Text] [Related]
12. Enzyme replacement therapy reduces Gaucher cell burden but may accelerate osteopenia in patients with type I disease - a histological study.
Rudzki Z; Okoń K; Machaczka M; Rucińska M; Papla B; Skotnicki AB
Eur J Haematol; 2003 May; 70(5):273-81. PubMed ID: 12694162
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging of bone marrow changes in Gaucher disease during enzyme replacement therapy: first German long-term results.
Poll LW; Koch JA; vom Dahl S; Willers R; Scherer A; Boerner D; Niederau C; Häussinger D; Mödder U
Skeletal Radiol; 2001 Sep; 30(9):496-503. PubMed ID: 11587517
[TBL] [Abstract][Full Text] [Related]
14. Gaucher disease and its treatment options.
Bennett LL; Mohan D
Ann Pharmacother; 2013 Sep; 47(9):1182-93. PubMed ID: 24259734
[TBL] [Abstract][Full Text] [Related]
15. Improvement In Symptoms Of Gaucher's Disease By Enzyme Replacement Therapy.
Mazher W; Ali J; Abubakar S; Basar S; Murtaza G
J Ayub Med Coll Abbottabad; 2018; 30(3):479-481. PubMed ID: 30465391
[TBL] [Abstract][Full Text] [Related]
16. Management of Gaucher disease: enzyme replacement therapy.
Zimran A; Elstein D
Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():82-7. PubMed ID: 25345089
[TBL] [Abstract][Full Text] [Related]
17. Neuronopathic Gaucher disease presenting with microcytic hypochromic anemia.
Kim EA; Lim YT; Hah JO; Sohn YB; Kim YK; Choi JH; Kim SY; Jang KM; Ahn J; Lee JM
Int J Hematol; 2019 Mar; 109(3):361-365. PubMed ID: 30456712
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy in a patient with chronic neuronopathic Gaucher disease: a case report.
Ceravolo F; Grisolia M; Sestito S; Falvo F; Moricca MT; Concolino D
J Med Case Rep; 2017 Jan; 11(1):19. PubMed ID: 28103924
[TBL] [Abstract][Full Text] [Related]
19. Minimal disease activity in Gaucher disease: criteria for definition.
Di Rocco M; Andria G; Bembi B; Carubbi F; Giona F; Giuffrida G; Linari S; Sibilio M; Spina V; Cappellini MD
Mol Genet Metab; 2012 Nov; 107(3):521-5. PubMed ID: 22954583
[TBL] [Abstract][Full Text] [Related]
20. [High dose of enzyme replacement therapy was successful for the pulmonary involvement in a case of type 2 Gaucher disease].
Arai N; Uematsu M; Abe Y; Fukuyo N; Wakusawa K; Kikuchi A; Sakamoto O; Ohura T; Tsuchiya S
No To Hattatsu; 2010 Jan; 42(1):45-9. PubMed ID: 23858612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
